TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCI To Proceed With Its Training Program Without Waiting For Implementation of Research Service Act September 20, 1974
TCL Archive In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds November 28, 1975
